Nilvadipine    (DrugBank: Nilvadipine)

1 disease
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa1

90. Retinitis pigmentosa    [ 103 clinical trials,   158 drugs,   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways]
Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 103 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000007895
2001/07/0101/06/2012Effects of nilvadipine on the progression of visual field defects in patients with retinitis pigmentosa retinitis pigmentosaTreated group: oral administration of nilvadipine 4mg per day

Control group: herenien, tocoferol or no medication as patients' requests
Department of Ophthalmology, Hirosaki University Graduate School of MedicineNULLComplete: follow-up complete20years-old80years-oldMale and Female40Phase 2Japan